Financial Gravity Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
Financial Gravity Asset Management's NVAX Position: Q2 2024 in Review
Financial Gravity Asset Management sold out of Novavax (NVAX) in Q2 2024, closing a stake of 22 shares — an estimated $102 sold.
Financial Gravity Asset Management first reported a position in NVAX in Q4 2020 and held it in 14 quarters. The position peaked at $212K in Q2 2021. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.
- Financial Gravity Asset Management reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
- Financial Gravity Asset Management sold 22 Novavax shares in Q2 2024, an estimated $102.
- Financial Gravity Asset Management first reported a position in Novavax in Q4 2020 and held it in 14 quarters.
- Financial Gravity Asset Management's Novavax position peaked at $212K in Q2 2021.
- 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.
Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.